Matinas BioPharma to Present at the 2017 Jefferies Global Healthcare Conference
Jun 01, 2017 11:28 am UTC| Business
BEDMINSTER, N.J., June 01, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that...
Matinas BioPharma to Present at the 2017 Jefferies Global Healthcare Conference
Jun 01, 2017 11:28 am UTC| Business
BEDMINSTER, N.J., June 01, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that...
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...
Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting
Jun 01, 2017 11:27 am UTC| Business
PRESS RELEASE Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting (Oxford, UK and Conshohocken, US, 1 June 2017) Immunocore Limited, the world's leading TCR company...
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...